SUPRIYA LIFESCIENCE LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 411 INR | +0.38% |
|
+13.03% | +30.60% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Supriya Lifescience Limited is an India-based manufacturer of active pharmaceutical ingredients (APIs). The Company is primarily engaged in manufacturing of bulk drugs and pharmaceutical chemicals. The Company exports its products in the antihistamine, anesthetics and anti-asthma therapy categories to approximately 86 countries. The Company's product portfolio consists of approximately 38 niche API products that address remedies in therapeutic segments, such as antihistamine, analgesic, vitamin, anesthetics and anti-asthmatics, among others. The Company has manufacturing facilities located in Maharashtra. Its products include Chlorphenamine Maleate, Pheniramine Maleate, Brompheniramine Maleate, Dexchlorpheniramine Maleate, Mepyramine / Pyrilamine Maleate, Dexbrompheniramine Maleate, Cetirizine DiHCL, Diphenhydramine HCL, Bisoprolol Fumarate, Nicorandil, Mecobalamin, Hydroxocobalamin Sulphate, Hydroxocobalamin Acetate, and Hydroxocobalamin Hydrochloride, among others.
Sector
Pharmaceuticals
Calendar
2024-04-29
- Investor Meeting - M3investment Managers
Trading Rating
Investor Rating
ESG Refinitiv
D+
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +30.60% | 395M | |
| +25.92% | 661B | |
| +26.74% | 566B | |
| -6.61% | 352B | |
| +19.51% | 332B | |
| +3.50% | 283B | |
| +13.43% | 231B | |
| +4.71% | 200B | |
| -9.53% | 195B | |
| -4.65% | 145B |
- Stock Market
- Equities
- SUPRIYA Stock
- News Supriya Lifescience Limited
- Supriya Lifescience Gets Brazil's Health Authority's GMP Certification for Site in India
